Popular Articles

Cardium Provides Update On Phase 2b Excellarate Clinical Study And Plans For Additional Tissue Repair Applications
Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy data for their Excellarate(TM) product candidate around the end of September. The MATRIX trial, a prospective, randomized, double-blind, placebo-controlled study, has enrolled 124 diabetic patients with non-healing, lower extremity neuropathic ulcers.

Navitar Optics Used In Military Applications For Over Sixty Years
Navitar, Inc."s cutting edge optical technology dates back over 60 years when the company"s founder, David Goldstein, pioneered his way into the optics industry. Originally forming Elgeet Optical in 1946, Goldstein set out to make innovative optics for the most revolutionary applications and industries. His decision to develop and manufacture optical technologies for Military applications was fundamental in establishing the Navitar name brand. Today, Navitar continues to develop product lines to meet changing technological advancements and is one of the most recognized and respected names in the optics industry.
News of the day
Lower Cancer Risk For Obese Women Who Underwent Weight-Loss Surgery
An article published Online First and in the July edition of The Lancet Oncology indicates that weight-loss surgery known as bariatric surgery could be linked to a reduction in cancer risk in obese women, but not in obese men.
Nutrition

New Diabetes Device Waves Good-Bye To Paper Log Books

Roche Diagnostics announces launch of new Accu-Chek Smart Pix diabetes management system for consumers. Traditionally, Accu-Chek Smart Pix has been an information management tool used by healthcare specialists in clinics, but now people with diabetes can benefit from this advanced technology for home use. With this brand new device, manual log books become a thing of the past, and patients remain fully in control of their diabetes at all times. The Accu-Chek Smart Pix reads results from the blood glucose meter or insulin pump, then displays them in easy-to-understand charts on the computer[i]. For the 2.5 million people diagnosed with diabetes[ii], tight glucose management is still the best way to manage fluctuations in blood sugar levels which can lead to complications like blindness and amputation[iii]. The speed and simplicity with which Smart Pix works allows patients to create reports, easily spot out-of-range readings and track patterns they may not have otherwise spotted. This can lead to better management of their condition and ultimately more freedom in their lifestyle. The results can be shared with healthcare professionals to enhance patient care. "Empowering a person with diabetes to manage their condition closely can make a huge difference to that person"s life," commented Dr Iain Cranston, Clinical Director from Queen Alexandra Hospital, Portsmouth. "Smart Pix enables patients to take control at home, as they can track their blood sugar levels and spot any trends through easy-to-read colourful graphics, thus avoiding the use of paper records. The patient is then able to see how alterations to their diet or lifestyle affect their condition and reap the long-term benefits of those intelligent choices. As a healthcare professional, I warmly welcome this device which provides actionable information, making consultations with patients more effective." The Accu-Chek Smart Pix is available at ÷£14.99[iv] by calling the Accu-Chek Care Line on 0800 701 000 (UK) or 1 800 709 600 (Republic of Ireland). The technology behind Smart Pix is constantly developing and complimentary software updates are available to download. Accu-Chek Smart Pix is compatible with all Accu-Chek blood glucose meters, including the slick new Accu-Chek Aviva Nano[v]. Visit http://www.accu-chek.co.uk/smartpix for more information. References [i] Accu-Chek Smart Pix connects to the computer via the USB port and reads results from the blood glucose meter or insulin pump via infrared [ii] Diabetes UK - 2009 [iii] Diabetes Control and Complications Trial on Type 1 diabetes (New England Journal of Medicine, 329(14), September 30, 1993); Martin S, Schneider B, Heinemann L, Lodwig V, Kurth H-J, Kolb H, Scherbaum W A: Self-monitoring of blood glucose in Type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia (2006) 49: 271-278 [iv] Note: For a limited period only [v] Note: Accu-Chek Smart Pix is not compatible with the Accu-Chek Advantage blood glucose meter Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):